Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2021 Filed May 20, 2021 21:01 UTC |
Chin MoonhieDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012950 · rdgdoc.xml · nonDerivative · entry 1 Chin Moonhie · CIK 0001395001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,707 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:58 UTC |
Gawlick RainerDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012948 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,779 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:57 UTC |
Goodman John BDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012946 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,106 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:54 UTC |
KRANTZ DONALD GDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012942 · rdgdoc.xml · nonDerivative · entry 1 KRANTZ DONALD G · CIK 0001183159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,264 F1 · shares: The restricted stock units vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2022 annual meeting of shareholders. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:51 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012939 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,906 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 04, 2021 Filed May 6, 2021 14:59 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Tax withholdingCommon Stock | 375 | $102.75 | $38,531.25 |
DisclosureSEC source: 0001437749-21-011051 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,613 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:53 UTC |
Goodman John BDirector
|
SaleCommon Stock | 1,000 | $151.19 | $151,185.00 |
DisclosureSEC source: 0001437749-21-004882 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,586 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:51 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantEmployee Stock Option (right to buy) · Derivative | 9,652 | $0.00 Strike: $150.86 | $0.00 |
DisclosureSEC source: 0001437749-21-004880 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,652 Underlying: Common Stock · 9,652 shares Expires 2031-03-01 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:51 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantCommon Stock | 4,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004880 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,556 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,910 | $0.00 Strike: $57.88 | $0.00 |
DisclosureSEC source: 0001437749-21-003288 · rdgdoc.xml · derivative · entry 6 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,910 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Tax withholdingCommon Stock | 3,619 | $197.05 | $713,123.95 |
DisclosureSEC source: 0001437749-21-003288 · rdgdoc.xml · nonDerivative · entry 5 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,840 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 1,258 | $189.28 | $238,119.52 |
DisclosureSEC source: 0001437749-21-003288 · rdgdoc.xml · nonDerivative · entry 4 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,459 F3 · price: Reflects the weighted average price of 1,258 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $189.17 to $189.77 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 9,540 | $188.53 | $1,798,607.68 |
DisclosureSEC source: 0001437749-21-003288 · rdgdoc.xml · nonDerivative · entry 3 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,717 F2 · price: Reflects the weighted average price of 9,540 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $188.12 to $189.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 8,112 | $187.66 | $1,522,314.14 |
DisclosureSEC source: 0001437749-21-003288 · rdgdoc.xml · nonDerivative · entry 2 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,257 F1 · price: Reflects the weighted average price of 8,112 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $187.11 to $188.04 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Exercise / conversionCommon Stock | 18,910 | $57.88 | $1,094,510.80 |
DisclosureSEC source: 0001437749-21-003288 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,442 | $0.00 Strike: $180.46 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · derivative · entry 14 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,442 Underlying: Common Stock · 3,442 shares Expires 2031-02-16 F10 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,628 | $0.00 Strike: $58.35 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · derivative · entry 13 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907 Underlying: Common Stock · 3,628 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2018. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,474 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · derivative · entry 12 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,737 Underlying: Common Stock · 3,474 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on May 4, 2017. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantCommon Stock | 4,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 11 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,988 F9 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Tax withholdingCommon Stock | 1,087 | $197.05 | $214,193.35 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 10 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,776 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 2,000 | $196.26 | $392,520.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 9 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,863 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 700 | $186.82 | $130,774.77 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 8 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,863 F6 · price: Reflects the weighted average price of 700 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $186.43 to $187.34 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 2,100 | $185.66 | $389,887.47 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 7 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,563 F5 · price: Reflects the weighted average price of 2,100 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $185.37 to $186.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 1,500 | $184.85 | $277,275.45 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 6 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,663 F4 · price: Reflects the weighted average price of 1,500 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $184.35 to $185.33 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 900 | $183.69 | $165,318.12 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 5 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,163 F3 · price: Reflects the weighted average price of 900 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $183.34 to $184.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 1,100 | $182.81 | $201,093.31 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 4 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,063 F2 · price: Reflects the weighted average price of 1,100 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $182.19 to $183.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 802 | $181.09 | $145,235.46 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 3 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,163 F1 · price: Reflects the weighted average price of 802 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $180.85 to $181.76 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Exercise / conversionCommon Stock | 3,628 | $58.35 | $211,693.80 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Exercise / conversionCommon Stock | 3,474 | $60.96 | $211,775.04 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,190 | $0.00 Strike: $180.46 | $0.00 |
DisclosureSEC source: 0001437749-21-003286 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Underlying: Common Stock · 2,190 shares Expires 2031-02-16 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantCommon Stock | 3,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-003286 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,247 F2 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC |
Bodor RobertVP/General Manager-Americas
|
Tax withholdingCommon Stock | 1,337 | $197.05 | $263,455.85 |
DisclosureSEC source: 0001437749-21-003286 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,143 F1 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 244 shares purchased on May 15, 2020 and 13 shares purchased on November 15, 2020 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:41 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantEmployee Stock Option (right to buy) · Derivative | 1,826 | $0.00 Strike: $180.46 | $0.00 |
DisclosureSEC source: 0001437749-21-003285 · rdgdoc.xml · derivative · entry 3 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,826 Underlying: Common Stock · 1,826 shares Expires 2031-02-16 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:41 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantCommon Stock | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-003285 · rdgdoc.xml · nonDerivative · entry 2 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,484 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:41 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
Tax withholdingCommon Stock | 455 | $197.05 | $89,657.75 |
DisclosureSEC source: 0001437749-21-003285 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,119 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:40 UTC |
WAY JOHNChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,128 | $0.00 Strike: $180.46 | $0.00 |
DisclosureSEC source: 0001437749-21-003284 · rdgdoc.xml · derivative · entry 3 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,128 Underlying: Common Stock · 3,128 shares Expires 2031-02-16 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:40 UTC |
WAY JOHNChief Financial Officer
|
GrantCommon Stock | 4,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-003284 · rdgdoc.xml · nonDerivative · entry 2 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,657 F2 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:40 UTC |
WAY JOHNChief Financial Officer
|
Tax withholdingCommon Stock | 2,171 | $197.05 | $427,795.55 |
DisclosureSEC source: 0001437749-21-003284 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,224 F1 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 133 shares purchased on May 15, 2020 and 112 shares purchased on November 15, 2020 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 21:18 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $53.34 | $0.00 |
DisclosureSEC source: 0001437749-20-025799 · rdgdoc.xml · derivative · entry 3 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 715 Underlying: Common Stock · 2,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 21:18 UTC |
Gawlick RainerDirector
|
SaleCommon Stock | 2,000 | $160.00 | $320,007.80 |
DisclosureSEC source: 0001437749-20-025799 · rdgdoc.xml · nonDerivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,259 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020. F3 · price: Reflects the weighted average price of 2,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on December 18, 2020 with sale prices ranging from $160.00 to $160.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 21:18 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 2,000 | $53.34 | $106,680.00 |
DisclosureSEC source: 0001437749-20-025799 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:19 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
Tax withholdingCommon Stock | 489 | $136.34 | $66,670.26 |
DisclosureSEC source: 0001437749-20-024773 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,574 Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,990 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · derivative · entry 10 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,990 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 800 | $161.14 | $128,912.00 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 9 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,459 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 400 | $159.19 | $63,676.00 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 8 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,259 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 1,200 | $157.81 | $189,368.04 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 7 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,659 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. F7 · price: Reflects the weighted average price of 1,200 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $157.66 to $157.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 2,330 | $156.60 | $364,881.96 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 6 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,859 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. F6 · price: Reflects the weighted average price of 2,330 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $156.14 to $157.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 3,158 | $155.50 | $491,061.11 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 5 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,189 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. F5 · price: Reflects the weighted average price of 3,158 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $155.04 to $155.91 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 3,219 | $154.45 | $497,160.39 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 4 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,347 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. F4 · price: Reflects the weighted average price of 3,219 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $153.97 to $154.89 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 2,617 | $153.69 | $402,196.26 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 3 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,566 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. F3 · price: Reflects the weighted average price of 2,617 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $152.97 to $153.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.